Life sciences news
-
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Wednesday July 28th 2021
Read more
-
Bone Therapeutics provides update on the progress of clinical studies
Monday July 19th 2021
Read more
-
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Thursday July 15th 2021
Read more
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Thursday July 15th 2021
Read more
-
Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump® study (POSEIDON)
Thursday July 1st 2021
Read more
-
Mithra completes recruitment of Covid-19 Phase II Study
Thursday June 17th 2021
Read more
-
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™
Monday June 14th 2021
Read more
-
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Friday June 4th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Wednesday May 19th 2021
Read more
-
Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme
Tuesday May 11th 2021
Read more
-
New cancer immunotherapy treatment enters clinical phase
Thursday April 29th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
